GLOBAL VETERINARY VACCINES MARKET 2019-2028

Lifesciences | Healthcare & Wellness

GLOBAL VETERINARY VACCINES MARKET 2019-2028

Market by Vaccine Type, Technology, Disease Type, and Geography | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global veterinary vaccines market by Triton Market Research shows that, in terms of revenue, the market is estimated to grow at a CAGR of 5.68% during the forecast years 2019-2028. It garnered $7.18 billion in 2019, and is expected to generate a revenue worth $11.80 billion by 2028.  


Report scope can be customized per your requirements. Request For Customization

Vaccines help develop naturally acquired immunity by stimulating the immune system with the help of either non-pathogenic organisms or by their immunogenic components. Veterinary vaccines are essential to increase the welfare of the animals, and reduce the monetary loss of their owners. These vaccines consist of attenuated and subunit vaccines that are useful in the prevention of diseases through their mode of action.

Also, the inclination of pet ownership by elderly people has surged in recent years, especially in developed countries. This is attributable to the rising number of elderly people living independently, along with various government programs constructed to assist in the welfare of pets owned by the geriatric population. Moreover, the animal vaccine market has experienced moderate growth in the last few years, owing to the emerging diseases affecting livestock and companion animals.



The study aims to get an overview of the veterinary vaccines market in terms of various factors. Within this report, the market definition and the key insights regarding the market have been discussed. Also, industry components, regulatory framework, vendor scorecard, Porter's five forces model, and market attractiveness index have been studied in detail.

The growing prevalence of zoonotic diseases and rising livestock diseases are primarily driving the veterinary vaccines market growth. However, the adverse effects of post-vaccination and shortage of skilled farmworkers are obstructing the growth of this market.

Key opportunities, such as the increasing number of initiatives by government agencies and growth in the momentum of pet ownership, can be leveraged by the market to reach the projected growth. However, the high costs of vaccinations is a challenge faced by this market.

Geographies covered in the veterinary vaccines market are:

•  North America: Canada and United States

Europe: Italy, Germany, Spain, United Kingdom, France, Russia, and Rest of Europe

Asia-Pacific: Japan, China, India, South Korea, ASEAN countries, New Zealand & Australia, and Rest of Asia-Pacific

Latin America: Mexico, Brazil, Argentina, and Rest of Latin America

• Middle East and Africa

The veterinary vaccines market has been segmented as follows:

•           By Vaccine Type

          o           Companion vaccine

                      •          Canine vaccine

                      •          Feline vaccine

                      •          Equine vaccine

          o           Livestock vaccine

                     •           Porcine vaccine

                     •           Bovine vaccine

                     •           Poultry vaccine

                     •           Aquaculture vaccine

                     •           Other livestock vaccines

•         By Technology

          o           Recombinant Vaccine

          o           Live Attenuated Vaccine

          o           Inactivated Vaccine

          o           Toxoid Vaccine

          o           Other Technology

•           By Disease Type

          o           Canine Disease

          o           Porcine Disease

          o           Bovine Disease

          o           Poultry Disease

          o           Aquaculture Disease

          o           Other Disease Type

The key players engaged in the veterinary vaccines market are Zoetis, Neogen Corporation, Ceva Sante Animale, Elanco (Eli Lilly And Company), HIPRA, Merck & Co, Boehringer Ingelheim Animal Health GmbH, Phibro Animal Health Corp, Hester Biosciences Limited, Romvac Company SA, Virbac SA, Vaxxinova GmbH-Germany, Anicon Labor GmbH, and Hygieia Biological Laboratories.     

The strategic analysis for each of these companies has been covered in detail. The veterinary vaccines market by company profiles helps to dive into the data about the key market players in this market. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL VETERINARY VACCINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   THREAT OF COMPETITIVE RIVALRY

2.3. IMPACT OF COVID-19 ON VETERINARY VACCINES MARKET

2.4. INDUSTRY COMPONENTS

2.5. REGULATORY FRAMEWORK

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. MARKET DRIVERS

2.8.1.   GROWTH IN PREVALENCE OF ZOONOTIC DISEASES

2.8.2.   RISE IN LIVESTOCK DISEASES

2.9. MARKET RESTRAINTS

2.9.1.   ADVERSE EFFECTS OF POST-VACCINATION

2.9.2.   SHORTAGE OF SKILLED FARMWORKERS

2.10.    MARKET OPPORTUNITIES

2.10.1.    INCREASE IN NUMBER OF INITIATIVES BY GOVERNMENT AGENCIES

2.10.2.     GROWTH IN MOMENTUM OF PET OWNERSHIP

2.11.    MARKET CHALLENGE

2.11.1.   HIGH COSTS OF VACCINATIONS

3.    GLOBAL VETERINARY VACCINES MARKET OUTLOOK - BY VACCINE TYPE

3.1. LIVESTOCK VACCINE

3.1.1.   PORCINE VACCINE

3.1.2.   BOVINE VACCINE

3.1.3.   POULTRY VACCINE

3.1.4.   AQUACULTURE VACCINE

3.1.5.   OTHER LIVESTOCK VACCINE

3.2. COMPANION VACCINE

3.2.1.   CANINE VACCINE

3.2.2.   FELINE VACCINE

3.2.3.   EQUINE VACCINE

4.    GLOBAL VETERINARY VACCINES MARKET OUTLOOK - BY TECHNOLOGY

4.1. LIVE ATTENUATED VACCINE

4.2. INACTIVATED VACCINE

4.3. RECOMBINANT VACCINE

4.4. TOXOID VACCINE

4.5. OTHER TECHNOLOGY

5.    GLOBAL VETERINARY VACCINES MARKET OUTLOOK - BY DISEASE TYPE

5.1. CANINE DISEASE

5.2. PORCINE DISEASE

5.3. BOVINE DISEASE

5.4. POULTRY DISEASE

5.5. AQUACULTURE DISEASE

5.6. OTHER DISEASE TYPE

6.    GLOBAL VETERINARY VACCINES MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY VACCINE TYPE

6.1.1.1.      MARKET BY LIVESTOCK VACCINE

6.1.1.2.      MARKET BY COMPANION VACCINE

6.1.2.   MARKET BY TECHNOLOGY

6.1.3.   MARKET BY DISEASE TYPE

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      THE UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY VACCINE TYPE

6.2.1.1.      MARKET BY LIVESTOCK VACCINE

6.2.1.2.      MARKET BY COMPANION VACCINE

6.2.2.   MARKET BY TECHNOLOGY

6.2.3.   MARKET BY DISEASE TYPE

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      THE UNITED KINGDOM

6.2.4.2.      FRANCE

6.2.4.3.      GERMANY

6.2.4.4.      ITALY

6.2.4.5.      RUSSIA

6.2.4.6.      SPAIN

6.2.4.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY VACCINE TYPE

6.3.1.1.      MARKET BY LIVESTOCK VACCINE

6.3.1.2.      MARKET BY COMPANION VACCINE

6.3.2.   MARKET BY TECHNOLOGY

6.3.3.   MARKET BY DISEASE TYPE

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      CHINA

6.3.4.2.      JAPAN

6.3.4.3.      INDIA

6.3.4.4.      AUSTRALIA & NEW ZEALAND

6.3.4.5.      SOUTH KOREA

6.3.4.6.      ASEAN COUNTRIES

6.3.4.7.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY VACCINE TYPE

6.4.1.1.      MARKET BY LIVESTOCK VACCINE

6.4.1.2.      MARKET BY COMPANION VACCINE

6.4.2.   MARKET BY TECHNOLOGY

6.4.3.   MARKET BY DISEASE TYPE

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      ARGENTINA

6.4.4.4.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY VACCINE TYPE

6.5.1.1.      MARKET BY LIVESTOCK VACCINE

6.5.1.2.      MARKET BY COMPANION VACCINE

6.5.2.   MARKET BY TECHNOLOGY

6.5.3.   MARKET BY DISEASE TYPE

6.5.4.   REGIONAL ANALYSIS

7.    COMPANY PROFILES

7.1. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH

7.2. CEVA SANTE ANIMALE

7.3. HYGIEIA BIOLOGICAL LABORATORIES

7.4. ANICON LABOR GMBH

7.5. PHIBRO ANIMAL HEALTH CORP

7.6. ROMVAC COMPANY SA

7.7. ELANCO (ELI LILLY AND COMPANY)

7.8. VAXXINOVA GMBH-GERMANY

7.9. ZOETIS

7.10.   HESTER BIOSCIENCES LIMITED

7.11.     HIPRA

7.12.    VIRBAC SA

7.13.    MERCK & CO

7.14.      NEOGEN CORPORATION

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS  

List of table

TABLE 1: GLOBAL VETERINARY VACCINES MARKET, BY REGION, 2019-2028 (IN $ MILLION)

TABLE 2: MARKET SNAPSHOT - VETERINARY VACCINE

TABLE 3: VENDOR SCORECARD

TABLE 4: GLOBAL VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 5: GLOBAL LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 6: COMMERCIALLY AVAILABLE PORCINE VACCINES

TABLE 7: COMMERCIALLY AVAILABLE POULTRY VACCINES

TABLE 8: GLOBAL COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 9: COMMERCIALLY AVAILABLE CANINE VACCINES

TABLE 10: COMMERCIALLY AVAILABLE FELINE VACCINES

TABLE 11: COMMERCIALLY AVAILABLE EQUINE VACCINES

TABLE 12: GLOBAL VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 13: GLOBAL VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

TABLE 14: GLOBAL VETERINARY VACCINES MARKET, BY REGION, 2019-2028 (IN $ MILLION)

TABLE 15: NORTH AMERICA VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 17: NORTH AMERICA COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 18: NORTH AMERICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 19: NORTH AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

TABLE 20: NORTH AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 21: EUROPE VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 22: EUROPE LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 23: EUROPE COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 24: EUROPE VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 25: EUROPE VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

TABLE 26: EUROPE VETERINARY VACCINES, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 28: ASIA-PACIFIC LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 29: ASIA-PACIFIC COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 30: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 31: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

TABLE 32: ASIA-PACIFIC VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 33: LATIN AMERICA VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 34: LATIN AMERICA LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 35: LATIN AMERICA COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 36: LATIN AMERICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 37: LATIN AMERICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

TABLE 38: LATIN AMERICA VETERINARY VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 39: MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY VACCINE TYPE, 2019-2028 (IN $ MILLION)

TABLE 40: MIDDLE EAST AND AFRICA LIVESTOCK VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 41: MIDDLE EAST AND AFRICA COMPANION VACCINE MARKET, BY TYPE, 2019-2028 (IN $ MILLION)

TABLE 42: MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 43: MIDDLE EAST AND AFRICA VETERINARY VACCINES MARKET, BY DISEASE TYPE, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: GLOBAL VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 2: GLOBAL VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 3: GLOBAL LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 4: GLOBAL LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 5: GLOBAL LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 6: GLOBAL LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 7: GLOBAL LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 8: GLOBAL VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 9: GLOBAL COMPANION VACCINE MARKET, BY CANINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 10: GLOBAL COMPANION VACCINE MARKET, BY FELINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 11: GLOBAL COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 12: GLOBAL VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 13: GLOBAL VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 14: GLOBAL VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 15: GLOBAL VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2019-2028 (IN $ MILLION)

FIGURE 16: GLOBAL VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2019-2028 (IN $ MILLION)

FIGURE 17: GLOBAL VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 18: GLOBAL VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 19: GLOBAL VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 20: GLOBAL VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 21: GLOBAL VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2019-2028 (IN $ MILLION)

FIGURE 22: GLOBAL VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2019-2028 (IN $ MILLION)

FIGURE 23: THE UNITED STATES VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 24: CANADA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 25: THE UNITED KINGDOM VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 26: FRANCE VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 27: GERMANY VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 28: ITALY VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 29: RUSSIA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 30: SPAIN VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 31: REST OF EUROPE VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 32: CHINA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 33: JAPAN VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 34: INDIA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 35: AUSTRALIA & NEW ZEALAND VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 36: SOUTH KOREA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 37: ASEAN COUNTRIES VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 38: REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 39: BRAZIL VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 40: MEXICO VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 41: ARGENTINA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

FIGURE 42: REST OF LATIN AMERICA VETERINARY VACCINES MARKET 2019-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;